List of Excipients in API olmesartan medoxomil, amlodipine and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing olmesartan medoxomil, amlodipine and hydrochlorothiazide
Detailed excipient profiles for olmesartan medoxomil, amlodipine and hydrochlorothiazide
Excipient focus: CELLULOSE, MICROCRYSTALLINE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing POLYVINYL ALCOHOL
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing SILICON DIOXIDE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing TALC
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
olmesartan medoxomil, amlodipine and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
